Je was op zoek naar: considered (Zweeds - Engels)

kontothe total for considered operations
account

in my considered opinion (enligt min väl övervägda mening)
in my considered opinion

the result of this test shall be considered satisfactory if the conditions set out in paragraphs 5.2. and 5.3. below are satisfied.
the result of this test shall be considered satisfactory if the conditions set out in paragraphs 5.2 and 5.3 below are satisfied.

på engelska “sugar not considered as ‘out-of-quota’ for export without refund.”
in english “sugar not considered as ‘out-of-quota’ for export without refund.”

choice of delta points to consider on the requirements for clinical documentation for metered dose inhalers addenda for neuropathic pains to be considered clinical investigation of hypnotic medicinal products clinical investigation of medical products in the treatment of generalised anxiety disorder, panic disorder and obsessive- compulsive disorderrevision note for guidance on anthiarrhythmics note for guidance on clinical investigation of steroid contraceptives in woman clinical investigation of corticosteroids intended for use on the skin note for guidance on pharmacokinetic studies in man points to consider on live attenuated influenza vaccines guidance on requirements for pharmaceutical/ clinical documentation for cell culture influenza vaccines points to consider on xenogeneic cell therapy note for guidance on comparability of medicinal products containing biotechnology- derived proteins as active substance note for guidance on the use of medicinal products during pregnancy: need for post- marketing data note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling revision of the note for guidance on harmonisation of requirements for influenza vaccines
note for guidance on pharmacokinetic studies in man points to consider on live attenuated influenza vaccines guidance on requirements for pharmaceutical/ clinical documentation for cell culture influenza vaccines points to consider on xenogeneic cell therapy note for guidance on comparability of medicinal products containing biotechnology-derived proteins as active substance note for guidance on the use of medicinal products during pregnancy: need for post-marketing data note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling revision of the note for guidance on harmonisation of requirements for influenza vaccines